Clinical Trial Update: BRCA1, RASSF1A and PTEN Methylation in Breast Lesions of Uncertain Malignant Potential [NA]

View source ↗

Summary

This clinical trial investigating BRCA1, RASSF1A, and PTEN methylation in breast cancer and breast lesions of uncertain malignant potential (B3 lesions) has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Lesions of Uncertain Malignant Potential

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Breast Cancer, Breast Lesions of Uncertain Malignant Potential (B3 Lesions) | NA | Status: COMPLETED